The piggyBac™ transposase technology is a non-viral, gene delivery system designed for use in many different research applications. With a large cargo capacity of over 200kb, piggyBac™ surpasses many other transposon and viral delivery vehicles, making it the optimal choice for stable cell line creation. The high efficiency and stability of piggyBac™ integration events have proven effective in a variety of genomes. To date, over 550 peer-reviewed papers have been published as a result of the piggyBac™ technology. Hera can use the piggyBac™ technology to create stable tumor cell lines for imaging with Luciferase or other reporters (i.e. TK for PET imaging).

How it works:



Learn More

piggyBac™ is a trademark of Transposagen
Cas-CLOVER™ is a trademark of Poseida Therapeutics